Explore Related Collections
Popular stories about Biotech Stocks
A $44 billion biotech just got some good news from the FDA about a key Alzheimer's drug, and the stock is soaring
The biotech giant Biogen just said US regulators will give its potential Alzheimer's treatment a speedy review, sending the company's stock soaring. The US Food and Drug Administration will rule on the...